Yun Chun Li
Net worth: 55 M $ as of 2026-08-30
Net worth: 55 M $ as of 2026-08-30
Presently, Yun Chun Li is Chairman at Walvax Biotechnology Co., Ltd. He is also on the board of Shanghai Zerun Biotech Co., Ltd., Genor Biopharma Co., Ltd. and Jiangsu Convac Biotechnology Co., Ltd.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-16 | 27,150,181 ( 1.74% ) | 55 M $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Chairman | 2009-06-22 |
Jiangsu Convac Biotechnology Co., Ltd.
Jiangsu Convac Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biological products | Director/Board Member | - |
Genor Biopharma Co., Ltd.
Genor Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody therapies | Director/Board Member | - |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Manufactures and distributes vaccine | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Walvax Biotechnology Co., Ltd.
Walvax Biotechnology Co., Ltd. BiotechnologyHealth Technology Engages in the research and development, production, and sale of human vaccine products | Health Technology |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Manufactures and distributes vaccine | Health Technology |
Genor Biopharma Co., Ltd.
Genor Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody therapies | Health Technology |
Jiangsu Convac Biotechnology Co., Ltd.
Jiangsu Convac Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biological products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions